Back
Intra-Cellular Therapies Stock Price Chart
Better Than Oil Stocks
CLICK HERE TO FIND OUT MORE
Buy
54
ITCI
Intra-Cellular Therapies
Last Price:
84.15
Seasonality Move:
17.89%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)- The current trend is moderately bearish and ITCI is experiencing buying pressure, which is a positive indicator for future bullish movement.
Intra-Cellular Therapies Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 84.74 | Sell |
| 20-day SMA: | 85.17 | Sell |
| 50-day SMA: | 81.61 | Buy |
| 200-day SMA: | 74.07 | Buy |
| 8-day EMA: | 84.52 | Sell |
| 20-day EMA: | 84.77 | Sell |
| 50-day EMA: | 82.49 | Buy |
| 200-day EMA: | 74.94 | Buy |
Intra-Cellular Therapies Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.35 | Buy |
| Relative Strength Index (14 RSI): | 48.15 | Sell |
| Chaikin Money Flow: | 341678 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (83.71 - 88.67) | Sell |
| Bollinger Bands (100): | (73.04 - 84.02) | Buy |
Intra-Cellular Therapies Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Intra-Cellular Therapies Stock
Is Intra-Cellular Therapies Stock a Buy?
- Intra-Cellular Therapies share price is 83.88 while ITCI 8-day simple moving average is 84.74, which is a Sell signal.
- The stock price of ITCI is 83.88 while Intra-Cellular Therapies 20-day SMA is 85.17, which makes it a Sell.
- Intra-Cellular Therapies 50-day simple moving average is 81.61 while ITCI share price is 83.88, making it a Buy technically.
- ITCI stock price is 83.88 and Intra-Cellular Therapies 200-day simple moving average is 74.07, creating a Buy signal.
ITCI Technical Analysis vs Fundamental Analysis
Buy
54
Intra-Cellular Therapies (ITCI)
is a Buy
Is Intra-Cellular Therapies a Buy or a Sell?
-
Intra-Cellular Therapies stock is rated a Buy
The current Intra-Cellular Therapies [ITCI] share price is $83.88. The Score for ITCI is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
Intra-Cellular Therapies Stock Info
Market Cap:
8.89B
Price in USD:
83.88
Share Volume:
434.44K
Intra-Cellular Therapies 52-Week Range
52-Week High:
93.45
52-Week Low:
62.78
Buy
54
Intra-Cellular Therapies (ITCI)
is a Buy
Intra-Cellular Therapies Share Price Forecast
-
What is the Intra-Cellular Therapies stock price today?
The Intra-Cellular Therapies stock price is 83.88 USD today. -
Will ITCI stock go up or go down?
Intra-Cellular Therapies> share price is forecast to RISE/FALL based on technical indicators -
Is Intra-Cellular Therapies overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intra-Cellular Therapies is not overvalued.
Is Intra-Cellular Therapies Stock a Buy?
- Intra-Cellular Therapies share price is 83.88 while ITCI 8-day exponential moving average is 84.52, which is a Sell signal.
- The stock price of ITCI is 83.88 while Intra-Cellular Therapies 20-day EMA is 84.77, which makes it a Sell.
- Intra-Cellular Therapies 50-day exponential moving average is 82.49 while ITCI share price is 83.88, making it a Buy technically.
- ITCI stock price is 83.88 and Intra-Cellular Therapies 200-day simple moving average is 74.94, creating a Buy signal.
Fundamental Analysis of Intra-Cellular Therapies
Is Intra-Cellular Therapies a good investment?
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.94 per share, and an increase next year of $0.91 per share.
Technical Analysis of Intra-Cellular Therapies
Should I short Intra-Cellular Therapies stock?
- ITCI Moving Average Covergence Divergence (MACD) indicator is 0.35, suggesting Intra-Cellular Therapies is a Buy
- Intra-Cellular Therapies Relative Strength Index (RSI) is 48.15, which suggest Intra-Cellular Therapies is oversold
- The Bollinger Bands (25) for Intra-Cellular Therapies is (83.71 - 88.67), which suggest Intra-Cellular Therapies is a Buy
- The Bollinger Bands (100) for Intra-Cellular Therapies is (73.04 - 84.02), which suggest Intra-Cellular Therapies is a Buy
* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.